International Trade Bulletin - Volume 1, Issue 2
Client Alert | 2 min read | 04.03.06
Inside this issue:
- CALIFORNIA IN THE SPOTLIGHT
- Wine Industry: The United States and the European Union have signed a bilateral wine trade agreement that will facilitate trade but also increase competition in the two wine markets
- Bilateral Trade: On March 8, the Bush Administration announced its latest plan to help U.S. exporters and importers do business in the Asia-Pacific market – a proposed U.S. – Malaysia Free Trade Agreement (FTA)
- EUROPE IN THE SPOTLIGHT
- Chemicals: New EU rules on the Registration, Evaluation and Authorization of Chemicals (REACH) will greatly affect the business reality for a large number of chemical companies as well as downstream users doing business in Europe and elsewhere
- Market Access: The EU and the U.S. are each other’s main trading partners, accounting for the largest bilateral trade relationship in the world
- EU TRADE REMEDIES: European Union Introduces “Flexible” Features into Its Anti-Dumping Measures
- WTO: The US and the EU have come together to request WTO consultations with China on its tariffs on automotive parts signaling an important change in the relationship among the three trading partners
- INVESTMENT: Investors clearly have begun to realize the significance of the rights guaranteed to them under NAFTA and other investment treaties, as well as their ability to enforce them
- US TRADE REMEDIES : Two initiatives currently underway in the U.S. government may make the prospects of bringing antidumping actions less attractive to U.S. petitioners
- SANCTIONS: The U.S. extraterritorial sanctions continue to wreak havoc with sourcing for companies worldwide
- CHINA EXPORT ISSUES: China "catch all" export control delayed but not dead; major review of China export policy underway
Insights
Client Alert | 15 min read | 08.20.25
In this eighth alert in our weekly series on the EU Pharma Package, we continue our overview of initiatives with respect to security of supply and shortage prevention and mitigation. Our last alert looked at how the Pharma Package seeks to address these issues. However, the Pharma Package does not exist in isolation, and in this alert we will discuss the interplay between its measures and those contained in other important EU initiatives such as the proposed Critical Medicines Act (CMA), and the Medicinal Countermeasures Strategy and the EU Stockpiling Strategy.
Client Alert | 4 min read | 08.19.25
Forged Faces, Real Liability: Deepfake Laws Take Effect in Washington State and Pennsylvania
Client Alert | 1 min read | 08.19.25
Client Alert | 3 min read | 08.18.25
FCPA Enforcement Continues to Evolve with Newly Unsealed Indictment
